In our study, TGFβr2 was increasingly expressed in TMCs, and the TGF-β/Smad signaling pathway was involved in the AGE-RAGE signaling pathway in diabetic complications (Fig. 8), leading to thrombogenesis, inflammation and atherosclerosis. This evidence concerns the gene TGFBR2 and atherosclerosis.